More data that will cause controversy in the screening debate

Data from a very large, 25-year-long, randomized, controlled trial of screening for cancer has cast further doubt on the value of mass, annual, population-based screening as a way to reduce cancer deaths. … READ MORE …

Other sessions from the GU Oncology Symposium on Thursday

While the late morning and afternoon oral presentations on Thursday at the Genitourinary Cancers Symposium were by no means boring, neither could any of them have been described as exactly “practice changing”. … READ MORE …

Should Gleason 6 really be called “cancer”? … A brief review

The January 15 issue of Oncology contains a review article by Lepor and Donin entitled “Gleason 6 prostate cancer: serious malignancy or toothless lion?”. … READ MORE …

The costs of new drugs to treat cancer (and other disorders)

In what is being described as “an extraordinary step” in some media reports, a group of more than 100 leukemia specialists has just published an article in the journal Blood asking for a real dialog with the biopharmaceutical industry about the constantly increasing costs associated with new (and older) drugs for the treatment of this form of cancer. … READ MORE …

How to cut your overall risk for all cancer by 51 percent, BUT …

There has been significant media coverage of a recent article in the journal Circulation. The article reports that individuals enrolled in the Atherosclerosis Risk in Communities (ARIC) study were able to cut their overall risk for cancer by 51 percent. … READ MORE …

The “cure” word and its use … by oncology specialists and their patients

As many readers will be aware, the word “cure” has to be used with caution in talking about any form of cancer — prostate cancer included. While “curative” therapy can be offered to a high proportion of men diagnosed with this condition, achieving a true “cure” is a less predictable opportunity, especially for men diagnosed with intermediate- and high-risk disease. … READ MORE …

Is the word “cancer” out of date? What’s in a name?

An article in today’s New York Times (“‘Cancer’ or ‘weird cells': which sounds deadlier?“) focuses on the question of whether many conditions currently referred to as “cancer” really are … and whether by calling them “cancer” we prejudice doctors and patients into taking overly aggressive action. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,322 other followers